Citigroup’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-207,496
| Closed | -$8.23M | – | 4973 |
|
|
2024
Q1 | $8.23M | Buy |
207,496
+171,719
| +480% | +$6.81M | 0.01% | 982 |
|
|
2023
Q4 | $682K | Buy |
35,777
+35,107
| +5,240% | +$669K | ﹤0.01% | 2463 |
|
|
2023
Q3 | $7.67K | Sell |
670
-9,606
| -93% | -$110K | ﹤0.01% | 3892 |
|
|
2023
Q2 | $106K | Buy |
10,276
+9,753
| +1,865% | +$100K | ﹤0.01% | 3556 |
|
|
2023
Q1 | $4.04K | Sell |
523
-71
| -12% | -$548 | ﹤0.01% | 4291 |
|
|
2022
Q4 | $4.37K | Sell |
594
-25
| -4% | -$184 | ﹤0.01% | 4324 |
|
|
2022
Q3 | $4K | Sell |
619
-978
| -61% | -$6.32K | ﹤0.01% | 4549 |
|
|
2022
Q2 | $14K | Buy |
1,597
+554
| +53% | +$4.86K | ﹤0.01% | 4491 |
|
|
2022
Q1 | $9K | Sell |
1,043
-2,723
| -72% | -$23.5K | ﹤0.01% | 4815 |
|
|
2021
Q4 | $52K | Buy |
3,766
+2,440
| +184% | +$33.7K | ﹤0.01% | 4280 |
|
|
2021
Q3 | $14K | Buy |
1,326
+774
| +140% | +$8.17K | ﹤0.01% | 4632 |
|
|
2021
Q2 | $5K | Sell |
552
-5,364
| -91% | -$48.6K | ﹤0.01% | 5177 |
|
|
2021
Q1 | $63K | Sell |
5,916
-2,980
| -33% | -$31.7K | ﹤0.01% | 3930 |
|
|
2020
Q4 | $112K | Buy |
+8,896
| New | +$112K | ﹤0.01% | 3611 |
|
|
2016
Q2 | – | Sell |
-1,046
| Closed | -$18K | – | 5341 |
|
|
2016
Q1 | $18K | Buy |
1,046
+1,041
| +20,820% | +$17.9K | ﹤0.01% | 4634 |
|
|
2015
Q4 | $0 | Buy |
5
+4
| +400% | – | ﹤0.01% | 5709 |
|
|
2015
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5591 |
|